(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

AVOTRES

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

AVOTRES

ST13

US500000088862881

Class

5

Filing

88862881

Registration

6225899

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

15

Latest update

12/23/2025

Trademark type

Word

Nice classes

5

Filing date

04/07/2020

Registration date

12/22/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/22/2020

Last transaction

12/23/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

06/20/2019

First use in commerce

06/20/2019

Drawing code

4

Owner type

03

Owner location

Westfield, NJ

Examiner

PEREZ,STEVEN M

Law office

L10

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Avotres Inc.

Representatives

Lisa B. Lane FOX ROTHSCHILD LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Diagnostic agentspreparations and substances for medical purposes; Diagnostic preparations for medical purposes; Medicinal preparations for the prevention and treatment of autoimmune diseases; Pharmaceutical preparations and medicinal therapy preparations for the prevention and treatment of endocrine and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of disorders of the immune system; Pharmaceutical preparations for the prevention and treatment of autoimmune diseases for use in endocrinology; Pharmaceutical preparations for the prevention and treatment of immunological disorders using biopharmaceutical or pharmaceutical agents

Publications

History of USPTO decisions and trademark events.

15 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

12/22/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

12/22/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/06/2020

PUBO

PUBLISHED FOR OPPOSITION

10/06/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/16/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/02/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/01/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/31/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/31/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

06/28/2020

GNRT

NON-FINAL ACTION E-MAILED

06/28/2020

CNRT

NON-FINAL ACTION WRITTEN

06/28/2020

DOCK

ASSIGNED TO EXAMINER

06/25/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/15/2020

NWAP

NEW APPLICATION ENTERED

04/10/2020

Continuous trademark protection

Get notified about every new filing that threatens AVOTRES or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.